S&P 500
(0.04%) 5 250.81 points
Dow J
(0.01%) 39 765 points
Nasdaq
(-0.09%) 16 384 points
Oil
(1.79%) $82.81
Gas
(0.52%) $1.727
Gold
(1.21%) $2 239.40
Silver
(1.03%) $25.01
Platinum
(1.41%) $922.55
USD/EUR
(0.24%) $0.926
USD/NOK
(0.64%) $10.84
USD/GBP
(-0.03%) $0.791
USD/RUB
(0.12%) $92.55

Realtime updates for Mesa Laboratories Inc [MLAB]

Exchange: NASDAQ Sector: Technology Industry: Scientific & Technical Instruments
BUY
50.00%
return 0.40%
SELL
0.00%
return 3.58%
Last Updated28 Mar 2024 @ 12:14

3.52% $ 111.02

SELL 62038 min ago

@ $92.30

Issued: 14 Feb 2024 @ 09:40


Return: 20.28%


Previous signal: Feb 13 - 09:30


Previous signal: Buy


Return: 0.53 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:14):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally...

Stats
Today's Volume 7 822.00
Average Volume 51 327.00
Market Cap 598.85M
EPS $0 ( 2024-02-05 )
Next earnings date ( $2.33 ) 2024-05-23
Last Dividend $0.160 ( 2023-11-29 )
Next Dividend $0 ( N/A )
P/E 653.06
ATR14 $0.304 (0.27%)
Insider Trading
Date Person Action Amount type
2024-01-08 Archbold Brian David Sell 290 Non Qualified Stock Option
2024-02-15 Capone Mark Christopher Buy 724 Restricted Stock Units -1
2024-01-08 Capone Mark Christopher Sell 0 MLAB
2023-12-15 Archbold Brian David Sell 1 500 Common Stock
2023-11-09 Sullivan John James Buy 200 Common Stock
INSIDER POWER
19.91
Last 100 transactions
Buy: 87 881 | Sell: 61 894

Volume Correlation

Long: 0.05 (neutral)
Short: -0.08 (neutral)
Signal:(84.712) Neutral

Mesa Laboratories Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mesa Laboratories Inc Correlation - Currency/Commodity

The country flag 0.79
( moderate )
The country flag 0.76
( moderate )
The country flag 0.75
( moderate )
The country flag -0.37
( neutral )
The country flag 0.39
( neutral )
The country flag 0.78
( moderate )

Mesa Laboratories Inc Financials

Annual 2023
Revenue: $219.08M
Gross Profit: $133.69M (61.02 %)
EPS: $0.170
Q4 2023
Revenue: $55.59M
Gross Profit: $33.20M (59.72 %)
EPS: $0.110
Q3 2023
Revenue: $54.29M
Gross Profit: $32.77M (60.36 %)
EPS: $0.0800
Q2 2023
Revenue: $58.75M
Gross Profit: $36.39M (61.93 %)
EPS: $0.250

Financial Reports:

No articles found.

Mesa Laboratories Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Mesa Laboratories Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.63 - good (76.32%) | Divividend Growth Potential Score: 5.80 - Stable (16.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.200 2003-11-26
Last Dividend $0.160 2023-11-29
Next Dividend $0 N/A
Payout Date 2023-12-15
Next Payout Date N/A
# dividends 81 --
Total Paid Out $11.06 --
Avg. Dividend % Per Year 0.19% --
Score 4.4 --
Div. Sustainability Score 7.63
Div.Growth Potential Score 5.80
Div. Directional Score 6.72 --
Next Divdend (Est)
(2024-04-01)
$0.164 Estimate 49.63 %
Dividend Stability
0.99 Excellent
Dividend Score
4.40
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2003 $0.200 3.07%
2004 $0.410 4.07%
2005 $0.500 3.85%
2006 $0.390 2.60%
2007 $0.340 1.80%
2008 $0.400 1.54%
2009 $0.410 2.27%
2010 $0.450 1.70%
2011 $0.490 1.63%
2012 $0.530 1.29%
2013 $0.570 1.08%
2014 $0.610 0.79%
2015 $0.640 0.80%
2016 $0.640 0.64%
2017 $0.640 0.52%
2018 $0.640 0.51%
2019 $0.640 0.31%
2020 $0.640 0.26%
2021 $0.640 0.23%
2022 $0.640 0.20%
2023 $0.640 0.37%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.004451.5009.9110.00[0 - 0.5]
returnOnAssetsTTM0.001281.2009.9610.00[0 - 0.3]
returnOnEquityTTM0.002411.500-1.084-1.626[0.1 - 1]
payoutRatioTTM3.63-1.00010.00-10.00[0 - 1]
currentRatioTTM2.680.8001.6061.285[1 - 3]
quickRatioTTM1.4540.8006.154.92[0.8 - 2.5]
cashRatioTTM0.6391.5007.5610.00[0.2 - 2]
debtRatioTTM0.318-1.5004.70-7.04[0 - 0.6]
interestCoverageTTM-2.031.000-1.862-1.862[3 - 30]
operatingCashFlowPerShareTTM8.122.007.2910.00[0 - 30]
freeCashFlowPerShareTTM7.552.006.2310.00[0 - 20]
debtEquityRatioTTM0.586-1.5007.66-10.00[0 - 2.5]
grossProfitMarginTTM0.6101.0003.163.16[0.2 - 0.8]
operatingProfitMarginTTM-0.04381.000-2.88-2.88[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1851.000-0.0812-0.0812[0.2 - 2]
assetTurnoverTTM0.2870.800-1.420-1.136[0.5 - 2]
Total Score7.63

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM610.131.00010.000[1 - 100]
returnOnEquityTTM0.002412.50-0.697-1.626[0.1 - 1.5]
freeCashFlowPerShareTTM7.552.007.4810.00[0 - 30]
dividendYielPercentageTTM0.5971.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.122.007.2910.00[0 - 30]
payoutRatioTTM3.631.50010.00-10.00[0 - 1]
pegRatioTTM1.7591.5001.6060[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2061.0007.360[0.1 - 0.5]
Total Score5.80

Mesa Laboratories Inc

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators